The carcinoembryonic antigen (CEA) has limited diagnostic utility: it is not a specific marker [20] and it is elevated at diagnosis only in 60%–70% of MTC patients [10, 11, 12, 21]. Here, CEACAM5 is linked to medullary thyroid gland carcinoma.